Description: BPH Energy Limited is engaged in investments in biotechnology entities and an oil and gas exploration entity. The Company's principal activities include Molecular Discovery Systems (MD Systems), HLS5 Project, Cortical Dynamics, Diagnostic Array Systems (DAS) and Advent Energy Limited. MD Systems a class of anti-mitotic drugs, which has undergone preclinical testing of anti-cancer activity. MD Systems is working with the Western Australian Institute for Medical Research to validate HLS5 as a tumor suppressor gene. Cortical Dynamics is working with BPH Energy and Swinburne University of Technology to commercialize anesthesia monitoring system for use during surgery. DAS is working with it to commercialize BacTrak, a diagnostic tool to enable pathology laboratories and emergency departments of hospitals to provide patients with identification of disease causing bacteria from a single sputum sample. Advent Energy Limited has its project in Petroleum Exploration Permit 11.
Home Page: www.bphenergy.com.au
BPH Technical Analysis
114 Cedric Street
Stirling,
WA
6021
Australia
Phone:
61 8 9328 8366
Officers
| Name | Title |
|---|---|
| Mr. David Leslie Breeze | Exec. Chairman, MD & Company Sec. |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.1531 |
| Price-to-Sales TTM: | 70.8869 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |